Reuters logo
Orion, Mylan settle patent dispute over Parkinson's drug Stalevo
July 25, 2013 / 8:41 AM / 4 years ago

Orion, Mylan settle patent dispute over Parkinson's drug Stalevo

HELSINKI, July 25 (Reuters) - Finnish drug maker Orion said that it settled a patent lawsuit in the United States against Mylan Pharmaceuticals over Mylan’s application to sell a generic version of Orion’s Parkinson’s drug Stalevo.

Orion did not disclose the terms of their settlement, but said Mylan would be authorised to launch generic versions of the Stalevo drug.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below